For citations:
Korolev M.A., Ubshaeva Yu.B., Banshchikova N.Y., Letyagina E.A., Mullagaliev A.A. The results of investigating the efficacy and safety of non-medical switching from the original rituximab to its biosimilar in rheumatoid arthritis patients (AMBIRA study). Rheumatology Science and Practice. 2020;58(6):663-672. (In Russ.) https://doi.org/10.47360/1995-4484-2020-663-672